JPMorgan Chase & Co. Increases ConvaTec Group (OTCMKTS:CNVVY) Price Target to GBX 320

ConvaTec Group (OTCMKTS:CNVVYGet Free Report) had its target price increased by investment analysts at JPMorgan Chase & Co. from GBX 290 ($3.72) to GBX 320 ($4.11) in a report issued on Thursday, FlyOnTheWall reports.

CNVVY has been the subject of a number of other research reports. Credit Suisse Group upped their price target on ConvaTec Group from GBX 220 ($2.82) to GBX 225 ($2.89) in a report on Tuesday, May 23rd. Morgan Stanley raised ConvaTec Group from an “equal weight” rating to an “overweight” rating in a report on Thursday, June 1st. Barclays increased their target price on ConvaTec Group from GBX 295 ($3.79) to GBX 300 ($3.85) in a report on Friday, May 19th. Finally, HSBC raised ConvaTec Group from a “reduce” rating to a “hold” rating in a report on Friday, July 7th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $272.50.

ConvaTec Group Stock Performance

Shares of CNVVY opened at $11.30 on Thursday. ConvaTec Group has a 52 week low of $8.69 and a 52 week high of $12.23. The stock’s 50-day moving average price is $10.74 and its 200-day moving average price is $10.93.

About ConvaTec Group

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

Further Reading

Analyst Recommendations for ConvaTec Group (OTCMKTS:CNVVY)

Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.